Thank you for posting.
Does this apply to HHV6, cytomegalovirus, or zoster as well? Or HSV1 or 2?
My ME/CFS was triggered by chemotherapy for stage 3 uterine/ovarian cancer. My immunoglobulins and NK cell function dropped and I had PCR positive EBV (with only high VCA IgG antibodies) along with 6 other infections. Autoimmunity was triggered. Extended use of high dose Valcyte, along with IVIG, testing the other infections, then using Rituximab led to significant resolution of symptoms. Therefore, though this article is significant, I am concerned about the assertions it makes regarding these treatments. My doctor, an AIDS doctor for 30 years, has been very careful about identifying a subset of patients to try these strategies on.
Additionally, my 2 Moderna COVID vaccines reactivated my HHV6, but not EBV (I've had several tests confirming this) and this time Valcyte was not fully effective, but I have been successful with both Valcyte and Famvir taken concurrently.
I believe this is a very significant area of investigation as I have known MANY patients who, after years of suffering, have finally been adequately tested for EBV, HHV6 and CMV, found them active, and subsequently responded to treatment.
The paper suggests current antivirals are inadequate. Many of us would be most grateful to better understand the DNA demethylation agents discussed in the paper.